Graham Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Graham Capital Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$337K	Buy	7,136 +435	+6%	+$22.4K	0.01%	858
2026 Q1	$397K	Sell	6,701 -493	-7%	-$32K	0.01%	704
2025 Q4	$444K	Sell	7,194 -192	-3%	-$11.8K	0.01%	673
2025 Q3	$461K	Buy	+7,386	New	+$514K	0.01%	652
2023 Q3	–	Sell	-11,875	Closed	-$706K	–	1222
2023 Q2	$706K	Buy	+11,875	New	+$711K	0.02%	462
2022 Q2	–	Sell	-31,630	Closed	-$1.67M	–	1188
2022 Q1	$1.67M	Buy	+31,630	New	+$1.83M	0.06%	163

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Graham Capital Management's PBH Position: Q2 2026 in Review

Graham Capital Management increased its Prestige Consumer Healthcare (PBH) stake by 6.5% in Q2 2026, buying an estimated $22.4K and bringing the position to 7,136 shares worth $337K. The position accounts for 0.01% of the portfolio, ranked #858.

Graham Capital Management first reported a position in PBH in Q1 2022 and has held it in 6 quarters since. The position peaked at $1.67M in Q1 2022. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

Graham Capital Management held 7,136 shares of Prestige Consumer Healthcare worth $337K as of Q2 2026.
Graham Capital Management bought 435 Prestige Consumer Healthcare shares in Q2 2026, an estimated $22.4K.
Prestige Consumer Healthcare made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #858 holding.
Graham Capital Management first reported a position in Prestige Consumer Healthcare in Q1 2022 and has held it in 6 quarters since.
Graham Capital Management's Prestige Consumer Healthcare position peaked at $1.67M in Q1 2022.
320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.